Avastin improves brain cancer survival
Cuma, 16.05.2008, 02:24am (GMT)
LOS ANGELES (Reuters) - Results from a mid-stage trial showed treatment with Genentech Inc's Avastin improved survival for patients with recurring brain cancer, the company said on Thursday.
Reuters Health News
|